The economic prognosis of the new analog of insulin glargine usage in diabetes mellitus type 2
Качественная клиническая практика, 2018 Modelling has been performed for evaluation of economic perspectives of new insulin glargine 300 IU/ml usage for diabetes mellitus type 2 (DM2) control based on literature analysis of non-direct comparison with insulin detemir.
D. Yu. Belousov, E. V. Afanasyeva
doaj
Indian Journal of Endocrinology and Metabolism, 2013 Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Debmalya Sanyal +2 more
doaj +1 more source
Design and rationale of a large, international, prospective cohort study to evaluate the occurrence of malformations and perinatal/neonatal death using insulin detemir in pregnant women with diabetes in comparison with other long-acting insulins [PDF]
, 2017 Elisabeth R. Mathiesen +3 more
openalex +1 more source
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 units/mL or Detemir 100) [PDF]
, 2023 Steven V. Edelman +7 more
openalex +1 more source
Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
Качественная клиническая практика, 2018 Usage of glucagon like peptide-1 receptors’ agonists (aGLP-1) is a new step in the treatment of Diabetes Mellitus Type 2 (DM 2). General attractive effects are positive effect on bodyweight, lower risk of hypoglycemia, compliance and possibility of ...
A. S. Kolbin +5 more
doaj
Indian Journal of Endocrinology and Metabolism, 2013 Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66 726) in routine clinical care ...
Othmane Laaribi
doaj +1 more source
Safety of once‐daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice (在常规临床实践中使用口服降糖药治疗的2型糖尿病患者每日一次使用地特胰岛素治疗的安全性) [PDF]
, 2013 Stuart A. Ross +10 more
openalex +1 more source
Therapeutic Advances in Endocrinology and Metabolism, 2018 Background: Diabetes mellitus type 1 (DM1) is an autoimmune disease characterized by metabolic destruction of pancreatic cells responsible for insulin production, with treatment based on replacing insulin.
Thales B. C. Silva +6 more
doaj +1 more source
Comparison of treatment with insulin Detemir and NPH in women with gestational diabetes mellitus: glycemic control and pregnancy outcomes [PDF]
, 2022 Paraskevi Kazakou +5 more
openalex +1 more source
Pakistan Journal of Medical ResearchBackground: The gestational diabetes mellitus (GDM) is one of the most common medical conditions during pregnancy. Insulin is considered to be safe in pregnancy.
Rukhsana Babar +5 more
doaj +2 more sources